Drug shortages in Lebanon threaten operations


  • English
  • Arabic

Lebanese intensive care units are running short on medicines, forcing hospitals to postpone operations as a severe economic crisis limits the country's ability to import life-saving drugs, doctors said on Wednesday.

"Medicines used only in intensive care units are missing," Dr Assem Araji, who heads parliament's Health Committee, said on Monday. "We are facing problems in ICUs.

“Medicines for heart diseases, diabetes, epilepsy and incurable illness are missing. People are searching for them from region to region and when they do find them it’s sold for twice the price,” Dr Araji said.

Medicine shortages are the latest sign of the Lebanese state's struggle to provide its population with basic needs since the onset of a financial crisis in late 2019.

Smuggling and hoarding of drugs as well as pressure from the coronavirus pandemic has worsened shortages that have become chronic in the past year and a half, Dr Araji said.

A closed pharmacy in Beirut, Lebanon. Patients and doctors report a dearth of mental health medicine across Lebanon as successive crises take their toll on its population. Xinhua
A closed pharmacy in Beirut, Lebanon. Patients and doctors report a dearth of mental health medicine across Lebanon as successive crises take their toll on its population. Xinhua

Lebanon imports 80 per cent of its drugs, the Medicine Importers Syndicate says, at a time when the country’s foreign currency reserves are at a record low. The country faces chronic shortages of fuel, food and other necessities, imported in dollars.

Firas Abiad, the director of Lebanon's largest public hospital, says hospitals are short on anaesthetics such as propofol and azneron, forcing doctors to postpone operations.

He said that lack of liquidity is preventing hospitals from building up enough stocks of crucial drugs in anticipation of the shortages.

"I am sure that soon we will see shortages of antibiotics and other medications," he told The National.

Drugs are subsidised by the Central Bank to keep pricing affordable amid rampant inflation, yet cheap prices encourage smuggling and hoarding, doctors and officials said.

“Smuggling has created artificial demand for medication,” Mr Abiad said. “And because people are scared they are hoarding, which worsens the shortages.”

People across the country are struggling to find the medicine they need, often visiting half a dozen pharmacies before they can buy their medications.

Lives at risk

Hawraa Faour, 36, said she has been running from pharmacy to pharmacy for the past two weeks to secure medication for her father, a paraplegic with diabetes and high blood pressure.

"I'm losing hope," she said. Her father has only one week's worth of drugs left.

Pharmacist Muhiddin Takkoush estimates that 150 to 200 common drugs are either in severe shortage in Lebanon or not available at all.

"It's a matter of life or death," Mr Takkoush said. "Even generic substitutes for missing medications are missing."

“Everything is missing, even painkillers. We have nothing to sell to people.”

The specs

Engine: four-litre V6 and 3.5-litre V6 twin-turbo

Transmission: six-speed and 10-speed

Power: 271 and 409 horsepower

Torque: 385 and 650Nm

Price: from Dh229,900 to Dh355,000

The past winners

2009 - Sebastian Vettel (Red Bull)

2010 - Sebastian Vettel (Red Bull)

2011 - Lewis Hamilton (McLaren)

2012 - Kimi Raikkonen (Lotus)

2013 - Sebastian Vettel (Red Bull)

2014 - Lewis Hamilton (Mercedes)

2015 - Nico Rosberg (Mercedes)

2016 - Lewis Hamilton (Mercedes)

2017 - Valtteri Bottas (Mercedes)

About Seez

Company name/date started: Seez, set up in September 2015 and the app was released in August 2017  

Founder/CEO name(s): Tarek Kabrit, co-founder and chief executive, and Andrew Kabrit, co-founder and chief operating officer

Based in: Dubai, with operations also in Kuwait, Saudi Arabia and Lebanon 

Sector:  Search engine for car buying, selling and leasing

Size: (employees/revenue): 11; undisclosed

Stage of funding: $1.8 million in seed funding; followed by another $1.5m bridge round - in the process of closing Series A 

Investors: Wamda Capital, B&Y and Phoenician Funds